Healthcare -
Biotechnology - NASDAQ - US
$ 0.8696
-0.046 %
$ 47.4 M
Market Cap
10.87
P/E
SPRO - NET INCOME
Net Income SPRO - Spero Therapeutics, Inc.
22.8 M
LAST VALUE
50.14%
2 YEAR CAGR
20.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR